Enterostatin
Enterostatin (Val-Pro-Asp-Pro-Arg)
5 aa Amino Acids · MW: 584 Da
Amino Acids
5 aa
Molecular Weight
584 Da
Half-life
minutes
Research Score
3.8
Studies
90
Storage
Store lyophilized at -20°C, reconstituted at 2-8°C
What is Enterostatin?
Enterostatin is a pentapeptide derived from procolipase that has been studied for reducing fat intake and appetite. It is one of the classic peptide signals associated with satiety and dietary fat preference.
Key Benefits & Mechanisms
reduced fat preference
lower caloric intake
decreased appetite
possible body-fat reduction
Research Summary
Enterostatin has been studied in both preclinical and limited human research for its effects on fat appetite and feeding behavior. The compound is notable for influencing macronutrient preference rather than only overall hunger.
Related Peptides
Oxyntomodulin
Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide
Oxyntomodulin is a naturally occurring proglucagon-derived peptide that activates GLP-1 and glucagon pathways. It is a key research tool for appetite suppression and energy balance studies in obesity.
Weight ManagementCotadutide
MEDI0382, long-acting GLP-1 and glucagon receptor dual agonist
Cotadutide is a synthetic oxyntomodulin analogue designed to engage both GLP-1 and glucagon receptors. It was developed to improve weight loss and metabolic markers in obesity and type 2 diabetes research.
Weight ManagementMazdutide
IBI362, long-acting GLP-1 receptor and glucagon receptor dual agonist
Mazdutide is a long-acting oxyntomodulin-inspired dual agonist being developed for obesity and metabolic disease. It is designed to drive clinically meaningful weight loss while improving glucose and lipid parameters.
Weight ManagementDulaglutide
Recombinant GLP-1 receptor agonist Fc fusion protein
Dulaglutide is a long-acting GLP-1 receptor agonist used primarily in type 2 diabetes. It consistently produces modest weight loss and is widely studied as a benchmark incretin mimetic.
Weight Management